Download PDF
Semin Respir Crit Care Med 1997; 18(5): 419-429
DOI: 10.1055/s-2007-1009357
Copyright © 1997 by Thieme Medical Publishers, Inc.

Epidemiology of Tuberculosis in the World

Francis Drobniewski* , A. Pablos-Méndez† , M. C. Raviglione‡
  • *UK Public Health Laboratory Service Mycobacterium Reference Unit, Dulwich Public Health Laboratory and Department of Microbiology, King's College School Medicine, London, United Kingdom
  • †Columbia University, New York
  • ‡World Health Organization, Geneva, Switzerland
Further Information

Publication History

Publication Date:
20 March 2008 (online)

  PDF Download  Permissions and Reprints

Abstract

Tuberculosis is the most important single cause of infectious disease in the world today, causing 8 million new cases and 3 deaths annually. Almost one third of the world's population is infected with the causative organism, Mycobacterium tuberculosis. The declining trend in cases ceased or reversed the developed and parts of the developing world during the 1980s. In most developing countries, especially in Africa and Asia, the trend continues to deteriorate due to failure give priority to, or poorly organized, programs with low case finding and cure, lack of international donors support, coinfection with the human immunodeficiency virus (HIV), increasing homelessness, and increasing institutional outbreaks. Although modern short course combination chemotherapy is highly effective, mortality rates remain high in these areas. Drug resistance, particularly resistance to isoniazid and rifampin (MDR-TB), poses a significant problem to control programs but with some exceptions has not been surveyed systematically; the WHO/IUATLD Global Surveillance Project was established to address this deficiency and its role is as described.

Key Words:

Tuberculosis - AIDS - multiple drug resistant tuberculosis - short-course chemotherapy

      >